The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
963
December 8, 1995
View Complete Issue         Table of Contents 2019 
Dalteparin - Another Low-Molecular-Weight Heparin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Dalteparin - Another Low-Molecular-Weight Heparin
December 8, 1995 (Issue: 963)
Dalteparin (Fragmin - Pharmacia), the second low-molecular-weight heparin to be marketed in the USA, is now available for prevention of deep vein thrombosis in high-risk patients after abdominal surgery. Enoxaparin (Lovenox -Rh ne-Poulenc Rorer) ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Dalteparin - Another Low-Molecular-Weight Heparin
Article code: 963c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.